Investing
GSK says FDA extends review period for experimental drug momelotinib
© Reuters. FILE PHOTO: GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File Photo
(Reuters) – British drugmaker GSK Plc on Friday said the U.S. Food and Drug Administration has extended the review period for its experimental drug momelotinib, which is designed to treat anaemic patients with a type of bone marrow cancer called myelofibrosis.
Momelotinib is not currently approved in any market.
Read the full article here
A Macy’s Employee Made Accounting Errors Worth $132 Million
Elon Musk Taught Himself to Code. Now It’s Your Turn.
5 Ways to Hire and Retain Top Talent in 2025
3 Simple Tips for Increasing Your Annual Recurring Revenue
Palantir assigned Street-high targets by Wedbush and BofA By Investing.com
How to Create a Unique Value Proposition (With Tips & Examples)
Are You Missing These Hidden Warning Signs When Hiring?
7 Common Things You Should Never Buy New
The DOJ Reportedly Wants Google to Sell Its Chrome Browser
This All-Access Pass to Learning Is Now $20 for Black Friday
Debt ceiling debate and its effect on the U.S. dollar
Debt ceiling default: Still no deal between parties
Stovall: If the U.S. defaults on its debt, all S&P 500 sectors will likely fall
What China's weaker-than-expected economy could mean for U.S. markets
A ‘Big Short’ investor sees financial disaster brewing in housing markets — again
-
Side Hustles6 days agoHow to Create a Unique Value Proposition (With Tips & Examples)
-
Investing5 days agoAre You Missing These Hidden Warning Signs When Hiring?
-
Make Money5 days ago7 Common Things You Should Never Buy New
-
Side Hustles6 days agoThe DOJ Reportedly Wants Google to Sell Its Chrome Browser
-
Investing2 days agoThis All-Access Pass to Learning Is Now $20 for Black Friday
-
Passive Income2 days agoHow to Create a Routine That Balances Rest and Business Success
-
Side Hustles3 days agoApple Prepares a New AI-Powered Siri to Compete With ChatGPT
-
Investing5 days agoGoogle faces call from DuckDuckGo for new EU probes into tech rule compliance By Reuters